From: Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer
Characteristics | N | BRD4 level | p-value | CAV-2 level | p-value | ||
---|---|---|---|---|---|---|---|
Low (26) | High (50) | Low (34) | High (42) | ||||
Age (years) | |||||||
 ≤ 60 | 23 | 5 | 18 | 0.131 | 8 | 15 | 0.250 |
 > 60 | 53 | 21 | 32 |  | 26 | 27 | |
Gender | |||||||
 Male | 49 | 18 | 31 | 0.532 | 22 | 27 | 0.970 |
 Female | 27 | 8 | 19 |  | 12 | 15 | |
Clinical stage | |||||||
 Early stages (≤ I) | 12 | 8 | 4 | 0.024* | 11 | 1 | < 0.001* |
 Advanced stages (> I) | 64 | 18 | 46 |  | 23 | 41 | |
Invasion depth | |||||||
 T1 + T2 | 17 | 8 | 9 | 0.205 | 12 | 5 | 0.015* |
 T3 + T4 | 59 | 18 | 41 |  | 22 | 37 | |
Lymph nodes metastasis | |||||||
 N0 (negative) | 33 | 16 | 17 | 0.022* | 21 | 12 | 0.004* |
 N1 (positive) | 43 | 10 | 33 |  | 13 | 30 | |
Distant metastasis | |||||||
 M0 (absent) | 72 | 25 | 47 | 1.000 | 33 | 39 | 0.765 |
 M1 (present) | 4 | 1 | 3 |  | 1 | 3 | |
Tumor differentiation | |||||||
 Well, moderate | 51 | 19 | 32 | 0.424 | 27 | 24 | 0.040* |
 Poor | 25 | 7 | 18 |  | 7 | 18 | |
Tumor location | |||||||
 Head, neck | 39 | 10 | 29 | 0.106 | 14 | 25 | 0.112 |
 Body, tail | 37 | 16 | 21 |  | 20 | 17 | |
Nervous invasion | |||||||
 Negative | 25 | 13 | 12 | 0.022* | 14 | 11 | 0.167 |
 Positive | 51 | 13 | 38 |  | 20 | 31 | |
Vessel invasion | |||||||
 Negative | 65 | 26 | 39 | 0.025* | 32 | 33 | 0.112 |
 Positive | 11 | 0 | 11 |  | 2 | 9 |